Identifying transcriptomic downstream targets of genes commonly mutated in Hereditary Hemorrhagic Telangiectasia
M. K. Ali, Y. Liu, K. Schimmel, N. H. Juul, C. A. Stockman, J. C. Wu, E. Spiekerkoetter
This study identifies common downstream transcriptomic targets of HHT-causing genes and discovers Brivanib as a potential therapeutic for HHT.
bioRxiv · Nov 25, 2022 · PreprintCell Biology